Ischemic heart disease Board decisions

The Board granted service connection for coronary artery disease due to presumed exposure to herbicide agents in service.

The Board remands the claim for compensation under 38 U.S.C. § 1151 for a heart disability to obtain additional evidence and a complete medical opinion.

The Board granted service connection for fecal incontinence as secondary to the Veteran's colon cancer residuals and denied a TDIU prior to April 21, 2024 and a higher rating for heart disability prior to that date. The claim for a higher rating for colon cancer residuals was remanded.

The Board granted service connection for a heart disability and peripheral neuropathy of the upper and lower extremities, as well as residuals of a stroke, resolving reasonable doubt in favor of the Veteran.

The Board denied earlier effective dates for service connection and ratings, except for TDIU and DEA which were granted as of May 1, 2020.

The Board granted service connection for valvular heart disease and hypertension, finding that these conditions are directly related to the Veteran's active duty service.

The Board denied service connection for ischemic heart disease (claimed as inferior infarction) because the evidence did not show a current diagnosis of the condition during the Veteran's lifetime.

The Veteran was granted special monthly compensation (SMC) based on the need for regular aid and attendance of another person from June 2, 2020, to November 11, 2021.

The Board denied the veteran's appeal for service connection for ischemic heart disease, residuals of a TBI, and residuals of a skull fracture due to the untimely filing of the appeal.

The Board denied the Veteran's claim for service connection for a heart disability, including due to inservice toxic risk exposure activities and secondary to his service-connected asbestosis.

The Board denied service connection for hypertension, a heart condition (coronary artery disease, ischemic heart disease, dilated cardiomyopathy), and digestive ulcers, finding no evidence of in-service exposure to herbicide agents or PCE, and no nexus between the conditions and service.

The Board granted service connection for a heart disability, MGUS, asymptomatic multiple myeloma, smoldering multiple myeloma, and peripheral neuropathy of the bilateral hands, forearms, lower legs, and feet based on toxic exposure risk activities during active service.

The Board granted service connection for obstructive sleep apnea (OSA) as secondary to the Veteran's service-connected disabilities. The claims for a heart disorder and prostate cancer were remanded.

The Board granted earlier effective dates for the grants of service connection for ischemic heart disease, anterior trunk scars, and PTSD.

The Board denied service connection for ischemic heart disease, cardiac hypertrophy, and an initial compensable rating for hypertension. The claims for a breathing condition and lung infection were remanded.

The Board granted earlier effective dates of January 16, 2002, for the grant of service connection for ischemic heart disease, diabetes mellitus type 2, and residuals of prostate cancer.

The Board denied service connection for a left shoulder disability and remanded claims for headaches, heart disease, hypertension, an acquired psychiatric disorder, a left leg condition, a lumbar spine issue, and right lower extremity radiculopathy.

The Board remands the claim for service connection of heart disease due to toxic exposure risk activity, including herbicide agent exposure, as it finds that there were pre-decisional duty to assist errors and requires additional development.

The Veteran's service-connected disabilities, including ischemic heart disease and unspecified trauma, rendered him unable to secure and follow a substantially gainful occupation.

The Board denied service connection for irregular heartbeat, psychiatric disability (anxiety disorder and PTSD), prostate disability (prostatitis and benign prostatic hypertrophy), and foot fungus. The appeal as to entitlement to an initial rating in excess of 10 percent for hypertension was dismissed.